Magnendo

Magnendo is an MIT spinout developing a magnetic robotic navigation platform for neuro-endovascular intervention. Its system combines magnetically steerable soft-robotic guidewires, robotic controls, medical imaging, and navigation software to improve access through complex brain vasculature. The company is focused initially on stroke intervention and brain aneurysm procedures, aiming to reduce navigation time, improve procedural consistency, and lower complications. As of July 24, 2026, Magnendo reported preclinical validation and is preparing its first clinical platform for first-in-human studies. The company appears to be a private, venture-backed medtech startup rather than a therapeutics developer.